Published in Transplant Proc on December 01, 1979
An improved method for isolation of H-2 and Ia alloantigens with immunoprecipitation induced by protein A-bearing staphylococci. J Immunol (1976) 4.55
Macrophage Ia antigens. I. macrophage populations differ in their expression of Ia antigens. J Immunol (1978) 4.04
Characterization of the cDNA encoding a protein binding to the major histocompatibility complex class II Y box. Proc Natl Acad Sci U S A (1988) 3.64
Isolation of H-2 alloantigens solubilized by the detergent NP-40. J Immunol (1971) 2.26
Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects. Arthritis Rheum (1998) 1.79
Safety of tacrolimus in patients with rheumatoid arthritis: long-term experience. Rheumatology (Oxford) (2004) 1.76
The distribution of alloantigenic specificities of native H-2 products. J Immunol (1972) 1.69
H-2 histocompatibility alloantigens. Some biochemical properties of the molecules solubilized by NP-40 detergent. Biochemistry (1973) 1.68
Studies of Ia antigens on murine peritoneal macrophages. Scand J Immunol (1976) 1.66
Fatal (chronic) granulomatous disease of childhood: a hereditary defect of leukocyte function. Semin Hematol (1968) 1.58
Regeneration of transplantation antigens on mouse cells. Transplant Proc (1971) 1.56
Guinea-pig Ia antigens: functional significance and chemical characterization. Transplant Rev (1976) 1.44
Association of HLA-DRw4 with rheumatoid arthritis in black and white patients. Arthritis Rheum (1980) 1.42
A new method for studying splenic reticuloendothelial dysfunction in sickle cell disease patients and its clinical application: a brief report. Blood (1976) 1.38
Defective candidacidal capacity of polymorphonuclear leukocytes in chronic granulomatous disease of childhood. J Pediatr (1969) 1.37
The in vitro response to phytohemagglutinin of lyphoid cells from normal and neonatally thymectomized adult mice. Int Arch Allergy Appl Immunol (1969) 1.35
Molecular relationships of the human B cell alloantigens, MT2, MB3, MT4, and DR5. J Immunol (1982) 1.34
Insertion of Ia and H-2 alloantigens into model membranes. Proc Natl Acad Sci U S A (1979) 1.31
Pocket 4 of the HLA-DR(alpha,beta 1*0401) molecule is a major determinant of T cells recognition of peptide. J Exp Med (1995) 1.28
Progressive loss in vitro of cellular immunity with ageing in strains of mice susceptible to autoimmune disease. Clin Exp Immunol (1971) 1.28
Defective bactericidal activity of monocytes in fatal granulomatous disease. Blood (1969) 1.27
Collagen-induced arthritis in the BB rat. Prevention of disease by treatment with CTLA-4-Ig. J Clin Invest (1995) 1.27
HLA-DR associates with specific stress proteins and is retained in the endoplasmic reticulum in invariant chain negative cells. J Exp Med (1992) 1.25
Complete sequence of the HLA DQ alpha and DQ beta cDNA from a DR5/DQw3 cell line. J Immunol (1987) 1.18
Alternative complement pathway activity in sera from patients with sickle cell disease. Clin Exp Immunol (1976) 1.15
Nitroblue-tetrazolium test in children with fatal granulomatous disease and newborn infants. Lancet (1969) 1.14
The molecular basis of codominant expression of the histocompatibility-2 genetic region. Proc Natl Acad Sci U S A (1972) 1.13
Biosynthetic relationships of the chondroitin sulfate proteoglycan with Ia and invariant chain glycoproteins. J Immunol (1985) 1.11
Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells. J Immunol (1995) 1.10
Structural identity of human histocompatibility leukocyte antigen-B27 molecules from patients with ankylosing spondylitis and normal individuals. J Clin Invest (1982) 1.10
Invariant chain is the core protein of the Ia-associated chondroitin sulfate proteoglycan. J Exp Med (1985) 1.09
Identification of a new component in the murine Ia molecular complex. J Exp Med (1983) 1.09
In vitro immunization to KLH. II. Limiting dilution analysis of antigen-reactive cells in primary and secondary culture. J Immunol (1983) 1.08
Purification of human brain tissue factor. J Biol Chem (1985) 1.08
In vitro response of human T cells to Pseudomonas aeruginosa. Infect Immun (1983) 1.07
The major histocompatibility complex of the guinea pig. I. Serologic and genetic studies. J Immunol (1975) 1.07
Complete characterization and sequence of an HLA class II DR beta chain cDNA from the DR5 haplotype. J Biol Chem (1986) 1.04
Identification of a sulfate-bearing molecule associated with HLA class II antigens. Proc Natl Acad Sci U S A (1984) 1.04
YB-1 DNA-binding protein represses interferon gamma activation of class II major histocompatibility complex genes. J Exp Med (1994) 1.03
Interactive effect of genes associated with immunoglobulin allotypes and HLA specificities on susceptibility to Haemophilus influenzae disease. J Immunogenet (1985) 1.02
Defective bactericidal activity of peripheral blood leukocytes in lipochrome histiocytosis. Am J Med (1970) 1.01
The guinea pig I region. II. Functional analysis. J Exp Med (1977) 1.01
Modification of the in vitro response to phytohemagglutinin of mouse spleen cells by amyloidogenic agents. Proc Soc Exp Biol Med (1969) 1.01
Automated synthesis of a C-terminal photoprobe using combined Fmoc and t-Boc synthesis strategies on a single automated peptide synthesizer. Pept Res (1992) 1.00
Structural characteristics of the alloantigens determined by the major histocompatibility complex of the guinea pig. J Exp Med (1976) 0.99
Corneal endothelial transplantation. Ophthalmology (1980) 0.98
Measurement of the fractional uptake of macromolecules by the renal vascular bed compared to other vascular beds. J Lab Clin Med (1976) 0.97
The human invariant chain is the core protein of the human class II-associated proteoglycan. J Exp Med (1986) 0.96
Azathioprine decreases suppressor T cells in patients with multiple sclerosis. N Engl J Med (1982) 0.96
Peptide characterization with a sulfoethyl aspartamide column. J Chromatogr (1988) 0.96
Characterization of two distinct DR beta chain alleles at the beta III locus of the DR5 haplotype: beta III alleles are highly conserved. J Immunol (1986) 0.96
Antigenic specificity of antibody reactive in the antiglobulin-augmented lymphocytotoxicity test. Transplantation (1982) 0.95
Mixed haplotypes and autoimmunity. Immunol Today (1993) 0.95
Response of peripheral blood lymphocytes from normal, hypogammaglobulinemic and chronic lymphocytic leukemic patients. J Immunol (1972) 0.95
Invariant chain influences post-translational processing of HLA-DR molecules. J Immunol (1991) 0.94
Recognition of the influenza hemagglutinin by class II MHC-restricted T lymphocytes and antibodies. I. Site definition and implications for antigen presentation and T lymphocyte recognition. J Immunol (1991) 0.94
Public epitopes and the antigenic structure of the HLA molecules. Crit Rev Immunol (1987) 0.94
Naturally processed peptides from rheumatoid arthritis associated and non-associated HLA-DR alleles. J Immunol (1995) 0.93
An HLA-DR5 homozygous cell line expresses two DS (I-A-like) molecules. J Exp Med (1983) 0.93
Mitral valve prolapse: a consistent manifestation of type IV Ehlers-Danlos syndrome. The pathogenetic role of the abnormal production of type III collagen. Circulation (1981) 0.93
Demonstration of a third structurally distinct human Ia beta chain by two-dimensional gel electrophoresis. J Exp Med (1982) 0.92
Further chemical characterization of guinea pig Ia molecules derived from the three major classes of immunocompetent cells. Mol Immunol (1979) 0.92
Successful transfusion of platelets "mismatched" for HLA antigens to alloimmunized thrombocytopenic patients. Am J Hematol (1977) 0.92
The sites in the I-Ak histocompatibility molecule photoaffinity labeled by an immunogenic lysozyme peptide. J Biol Chem (1990) 0.92
In vitro primary immunization of human peripheral blood lymphocytes to KLH: evidence for HLA-D region restriction. J Immunol (1979) 0.91
The guinea-pig I-region. III. Distribution of Ia antigens in inbred and partially inbred strains. J Immunogenet (1980) 0.91
Negatively charged residues interacting with the p4 pocket confer binding specificity to DRB1*0401. Arthritis Rheum (1995) 0.89
Inhibition of normal allogeneic responder cells in mouse mixed leukocyte culture by long-passage AKR leukemic lymphoblasts. Cancer Res (1974) 0.89
Public antigenic determinant on a family of HLA-B molecules. J Clin Invest (1979) 0.88
HLA-DR specificities among black Americans with juvenile-onset diabetes. N Engl J Med (1979) 0.88
A gelatin membrane substrate for the transplantation of tissue cultured cells. Transplantation (1980) 0.87
Low incidence of red cell and HLA antibody formation by bone marrow transplant patients. Transfusion (1996) 0.86
The guinea pig I region. I. A structural and genetic analysis. J Exp Med (1977) 0.86
Temporal integration deficit in visual information processing by chronic schizophrenics. Biol Psychiatry (1983) 0.86
Pretreatment of renal allograft recipients with immunosuppression and donor-specific blood. Transplantation (1984) 0.85
A human alloantiserum precipitates Ia-like molecules from chronic lymphocytic leukemia cells. J Immunol (1977) 0.85
Disordered spatiotemporal processing in schizophrenics. Biol Psychiatry (1987) 0.85
Xyloside inhibits synthesis of the class II-associated chondroitin sulfate proteoglycan and antigen presentation events. J Immunol (1987) 0.85
Clinical and histological assessment of collagen-induced arthritis progression in the diabetes-resistant BB/Wor rat. Toxicol Pathol (1997) 0.84
Partial chemical characterization of Ia antigens derived from murine thymocytes. Proc Natl Acad Sci U S A (1977) 0.84
Morphology of transplanted corneal endothelium derived from tissue culture. Invest Ophthalmol Vis Sci (1981) 0.84
A unique DR-related B cell differentiation antigen. J Immunol (1983) 0.83
The development and specificity of antiidiotypic antibodies in renal transplant recipients receiving single-donor blood transfusions. Transplantation (1989) 0.83
Cellular distribution of the Ia-associated chondroitin sulfate proteoglycan. J Immunol (1985) 0.83
Murine I-Ak alpha-chain subspecies with glycosylation differences. J Immunol (1982) 0.82
IgA deficiency, antigenic barriers, and autoimmunity. Cell Immunol (1970) 0.82
Analysis of murine Ia antigen glycosylation by lectin affinity chromatography. I-Ak alpha chain subspecies and beta chains are each glycosylated differently. J Biol Chem (1982) 0.82
Antiretroviral antibodies: implications for schizophrenia, schizophrenia spectrum disorders, and bipolar disorder. Biol Psychiatry (1999) 0.81
Multiple mechanisms produce diversity of HLA-C alleles. Hum Immunol (1990) 0.81
Histocompatibility antigens of human plasma. Localization to the HLD-3 lipoprotein fraction. Transplantation (1973) 0.81
The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis. Biol Blood Marrow Transplant (1997) 0.81
A unique sequence of the NZW I-E beta chain and its possible contribution to autoimmunity in the (NZB x NZW)F1 mouse. J Exp Med (1989) 0.81
Facile analysis and purification of deblocked N-terminal pyroglutamyl peptides with a strong cation-exchange sulfoethyl aspartamide column. Biochem Biophys Res Commun (1988) 0.81